Bio-Techne (TECH) Stock Price, Quote, News & History | Benzinga

Bio-Techne Corp (TECH) Stock Price, Quote, News & History

TECHNASDAQ

Trade with Public

Trade with Public

$72.30

0.120.17%

At close: Sep 1, 5:00 PM EST

$72.21

0.030.04%

Pre-Market: 4:11 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

-

Close

$72.30

Volume / Avg.

1.74K / 4.68M

Day Range

- - -

52 Wk Range

43.20 - 72.62

Market Cap

$11.32B

P/E Ratio

62.34

Dividend Yield

0.44%

Exchange

NASDAQ

RSI

61

Short Interest

4.7%

Days to Cover

2.27

Recent Bio-Techne Corporation News

Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover

Private equity giants circle Qiagen (QGEN) with potential bids of $50/share. Get the details on the molecular diagnostics buyout.

Vandana Singh

Micron Rallies 15%, Apple Sinks 6% On Memory Costs: Stock Market Today

Micron's blowout earnings powered memory and chip stocks higher, but the broad stock market rally stalled by midday as S&P 500 slipped.

Piero Cingari

Acuity Posts Strong Q3 Results, Joins BlackBerry, MillerKnoll, Qualcomm And Other Big Stocks Moving Higher On Thursday

Dow Jones index gained 200 points; Acuity Inc (NYSE: AYI) reported better-than-expected financial results, shares rose 17.1%; other big stocks also gained.

Avi Kapoor

Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal

Merck KGaA is acquiring Bio-Techne in an $11.3B all-cash deal to expand its life science, diagnostics, and bioprocessing footprint.

Vandana Singh

S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today

U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

292.07M

Investing Cash Flow (TTM)

-18.19M

Financing Cash Flow (TTM)

-169.11M

Free Cash Flow (TTM)

263.22M

Capital Expenditure (TTM)

-28.85M

Net Change in Cash (TTM)

104.77M

Analyst Trends and Forecast

0

0

0

0

Apr

3

May

5

Jun

0

0

0

0

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.7

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$11.37B

PE Ratio (TTM)

62.34

PE Ratio (FWD)

34.48

PEG Ratio (TTM)

2.10

PS Ratio (TTM)

9.35

PB Ratio (TTM)

5.38

Earnings Yield % (TTM)

1.60%

Earnings Yield % (FWD)

2.90%

EV / EBITDA (TTM)

32.69

Price / EBITDA (TTM)

32.66

Price / Free Cash Flow (TTM)

43.14

Book Value / Share

$13.44

Company Debt

Total Debt

$200.00M

LT Debt

$200.00M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$146.00M

Total Cash

$264.71M

Debt to Equity

0.14

Issuance of Debt (TTM)

-$146.00M

Repayment of Debt (TTM)

-$146.00M

Key Statistics

Open

-

Close

$72.30

Volume / Avg.

1.74K / 4.68M

Day Range

- - -

52 Wk Range

43.20 - 72.62

Market Cap

$11.32B

P/E Ratio

62.34

Dividend Yield

0.44%

Exchange

NASDAQ

RSI

61

Short Interest

4.7%

Days to Cover

2.27

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and ge...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Bio-Techne (TECH) stock?

A

You can purchase shares of Bio-Techne (NASDAQ:TECH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Bio-Techne (TECH) competitors?

A

Other companies in Bio-Techne’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), IQVIA Holdings Inc (NYSE:IQV), Agilent Technologies Inc (NYSE:A) and Waters Corp (NYSE:WAT).

Q

What is the forecast, or price target, for Bio-Techne (TECH) stock?

A

Bio-Techne has a consensus price target of $72.17.

Q

What is the current price for Bio-Techne (TECH)?

A

The stock price for Bio-Techne (NASDAQ: TECH) is $72.21 last updated September 3, 2026 at 4:11 AM EDT.

Q

Does Bio-Techne (TECH) pay a dividend?

A

There are no upcoming dividends for Bio-Techne.

Q

When is Bio-Techne (NASDAQ:TECH) reporting earnings?

A

Bio-Techne does not have any upcoming earnings scheduled.

Q

Is Bio-Techne (TECH) going to split?

A

There is no upcoming split for Bio-Techne.

Q

What sector and industry does Bio-Techne (TECH) operate in?

A

Bio-Techne is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.